Monkeypox Treatment Research Gains Momentum in Africa
Research into effective treatments for monkeypox in Africa is showing promising progress. A clinical study led by the Africa Centers for Disease Control and Prevention (Africa CDC) has received a positive review of its initial safety data, paving the way for continued investigation into potential therapies for the disease. Currently,no specific treatment for monkeypox exists.
An autonomous Data and Safety Monitoring Board (DSMB) has recommended the study proceed after a preliminary review of data from the first 50 patients revealed no notable safety concerns. This positive assessment bolsters confidence in the ongoing scientific research across the continent.
The study is slated to fully launch in 2024, representing a collaborative effort between African nations and international partners to strengthen the response to emerging infectious diseases. Initial efforts will be concentrated in the Democratic republic of the Congo, with plans to expand the study to include othre African countries, such as Uganda, in subsequent phases.
According to the Africa CDC, more then 61,000 confirmed cases of monkeypox and approximately 300 deaths have been recorded across 32 African countries since the start of 2024. The Africa CDC emphasizes that these positive research results are a crucial step towards establishing the scientific evidence needed to guide monkeypox treatment protocols and improve Africa’s preparedness for future public health challenges.